Status:
COMPLETED
Cardiovascular Function in Acute Leukemia
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Conditions:
Leukemia, Myeloid, Acute
Leukemia, Lymphoid, Acute
Eligibility:
All Genders
18-90 years
Brief Summary
An observational, prospective study to describe the rates and predictors of cardiovascular events in patients with acute leukemia.
Detailed Description
Patients recently diagnosed with acute leukemia and who will initiating chemotherapy will be enrolled and followed serially with blood collection, echocardiogram, arterial applanation tonometry, and q...
Eligibility Criteria
Inclusion
- Older than 18 years of age,
- New diagnosis of untreated acute leukemia (prior treatment for myelodysplastic syndrome or myeloproliferative neoplams or prior treatment with an anthracycline for breast cancer, Hodgkin's lymphoma, non-Hodgkin's lymphoma or another diagnosis will be included).
- Signed the informed consent form
Exclusion
- • Unable to provide informed consent
Key Trial Info
Start Date :
December 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 6 2024
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT03760237
Start Date
December 10 2018
End Date
May 6 2024
Last Update
October 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104